Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

MARKER THERAPEUTICS, INC. (MRKR) vs Psyence Biomedical Ltd. (PBM)

MARKER THERAPEUTICS, INC. and Psyence Biomedical Ltd. are both Biotechnology companies. Psyence Biomedical Ltd. is the larger, with a market value of $22.4M against $19.8M — 1.1× the size. MARKER THERAPEUTICS, INC. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 10 metrics below, Psyence Biomedical Ltd. leads on 8 and MARKER THERAPEUTICS, INC. on 2.

Valuation

Metric MRKR PBM Biotechnology median
P/E n/m 0.25 7.88
P/S 4.67 n/m 11.47
P/B 1.83 0.11 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.73 0.74
EV/Sales 2.33 n/m 10.73
Earnings yield (35.65%) 405.89% (28.84%)
Free cash flow yield (98.59%) (613.04%) (23.03%)

Profitability

Metric MRKR PBM Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.87%) (23.52%) (57.72%)
Return on assets (59.33%) (15.37%) (49.22%)
Return on invested capital (566.75%) 0.00% 0.00%

Growth

Metric MRKR PBM Biotechnology median
Revenue growth (TTM) (27.83%) — 5.64%
EPS growth (last fiscal year) 33.61% (138.35%) —
Revenue growth, 5-year CAGR 50.02% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRKR PBM Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 6.03 8.09 4.73
Net debt to EBITDA 1.32 1.20 0.96

Dividend

Metric MRKR PBM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MRKR PBM Biotechnology median
Market cap 19.84m 22.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack